期刊文献+

抗原递呈细胞在异基因造血干细胞移植中的研究进展 被引量:1

下载PDF
导出
出处 《东南大学学报(医学版)》 CAS 2006年第2期122-125,共4页 Journal of Southeast University(Medical Science Edition)
基金 江苏省自然科学基金资助项目(BK1999126) 南京市重大课题基金资助项目(Yq0008) 东南大学中大医院重大课题基金资助项目(2003YJ02)
  • 引文网络
  • 相关文献

参考文献18

  • 1ZHANG Y,JOE G,ZHU J,et al.Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity[J].Blood,2004,103(10):3970-3978.
  • 2DUFFNER U A,MAEDA Y,COOKE K R,et al.Host dendriticcells alone are sufficient to initiate acute graft-versus-host disease[J].J Immunol,2004,172(12):7393-7398.
  • 3MATTE C C,LIU J,CORMIER J,et al.Donor APCs are required for maximal GVHD but not for GVL[J].Nat Med,2004,10(9):987-992.
  • 4GIVER C R,LI J M,HOSSAIN M S,et al.Reconstructing immunity after allogeneic transplantation[J].Immunol Res,2004,29(1-3):269-282.
  • 5GODFREY W R,KRAMPF M R,TAYLOR P A,et al.Ex vivo depletion of alloreactive cells based on CFSE dye dilution,activation antigen selection,and dendritic cell stimulation[J].Blood,2004,103(3):1158-1165.
  • 6SATO K,YAMASHITA N,BABA M,et al.Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells[J].Blood,2003,101(9):3581-3589.
  • 7MACDONALD K P,ROWE V,FILIPPICH C T,et al.Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation[J].Blood,2003,101(5):2033-2042.
  • 8FAGNONI F F,OLIVIERO B,GIORGIANI G,et al.Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation[J].Blood,2004,104(1):281-289.
  • 9CHKLOVSKAIA E,NOWBAKHT P,NISSEN C,et al.Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation:effects of endogenous flt3 ligand[J].Blood,2004,103(10):3860-3868.
  • 10URBINI B,ARPINATI M,BONIFAZI F,et al.Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome,but not with dendritic cell reconstitution after transplant[J].Exp Hematol,2003,31(10):959-965.

同被引文献17

  • 1FLEMING J N,HOSTIKKA S L,CHEN E Y,et al.Plasmacytoid dendritic cells and interferon levels are increased in lymphatic malformations[J].Otolaryngol Head Neck Surg,2008,139(5):671-676.
  • 2ZOU G M,MARTINSON J,HU W Y,et al.The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients[J].Cancer Immunol Immunother,2004,53(8):681-689.
  • 3CHAUVIN C,JOSIEN R.Dendritic cells as killers:mechanistic aspects and potential roles[J].Immunol,2008,181:11-16.
  • 4BANCHEREAU J,STEINMAN R M.Dendritic cells and the control of immunity[J].Nature,1998,392:245-252.
  • 5DOMINQUEZ-SOTO A,CORBI A L.Myeloid dendritic cell lectins and their role in immune responses[J].Curr Opin Investig Drugs,2007,8:910-920.
  • 6BRUNO L.Differentiation of dendritic cell subsets from mouse bone marrow[J].Methods Mol Biol,2007,380:47-57.
  • 7OGAWA F,IINUMA H,OKINAGA K.Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced,spleen-derived dendritic cells and tumour cells[J].Scand J Immunol,2004,59:432-439.
  • 8den BROK M H,NIERKENS S,FIGDOR C G,et al.Dendritic cells:tools and targets for antitumor vaccination[J].Expert Rev Vaccines,2005,4:699-710.
  • 9BANCHEREAU J,PALUCKA A K.Dendritic cells as therapeutic vaccines against cancer[J].Nat Rev Immunol,2005,5:296-306.
  • 10GONG J,KOIDO S,CALDERWOOD S K.Cell fusion:from hybridoma to dendritic cell-based vaccine[J].Expert Rev Vaccines,2008,7:1055-1068.

引证文献1

二级引证文献1

;
使用帮助 返回顶部